Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

SmithKline Beecham presents new azetidinones for atherosclerosis

Jan. 23, 1998

Japan Energy describes inhibitors of SMC proliferation

Jan. 22, 1998

Novel coronary artery disease gene therapy scheduled to enter clinical trials

Jan. 21, 1998

Hemodynamic profile of new K+ channel activator

Jan. 21, 1998

CVT-313: promising antiproliferative agent that inhibits CDK2

Jan. 20, 1998

SmithKline Beecham develops Lp-PLA2 inhibitors for atherosclerosis

Jan. 20, 1998

CV Therapeutics seeks permission to move CVT-510 to clinical trials

Jan. 20, 1998

Cardizem Monovial now available in U.S.

Jan. 19, 1998

Novartis reveals agents for atherosclerosis and chronic inflammation

Jan. 19, 1998

Inhibition of monocyte-endothelial cell adhesion in atherogenesis by anti-CD43 MAb

Jan. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...